Filing Flows › Jaguar Health (JAGX) › R&D spending
Jaguar Health (JAGX) R&D spending by quarter
Jaguar Health's R&D spending was $3.3M in Q2 2026 (second quarter 2026), -15% from Q1 2026. Over the last 7 quarters it ranged from $3.3M (Q2 2025) to $14.3M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.3M | -15% | +2% |
| Q1 2026 | $3.9M | -73% | +5% |
| Q4 2025 | $14.3M | +291% | +216% |
| Q3 2025 | $3.7M | +12% | — |
| Q2 2025 | $3.3M | -12% | — |
| Q1 2025 | $3.7M | -18% | — |
| Q4 2024 | $4.5M | — | — |
Q2 2026 at a glance
Jaguar Health, Q2 2026: revenue $1.2M (-59% year over year), operating margin -620.2%, net loss $12.8M, operating cash flow −$5.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Jaguar Health's R&D spending?
Jaguar Health's R&D spending was $3.3M in Q2 2026 (second quarter 2026), -15% from Q1 2026.
How has Jaguar Health's R&D spending changed?
Over the last 7 quarters it ranged from $3.3M (Q2 2025) to $14.3M (Q4 2025).